Jump to Navigation
Home ›

ADHD > Article

A Boatload of New Data on Stimulants and Cardiac Events

In 2006, an FDA panel recommended all manufacturers of stimulants to add a “black box” warning about an increased risk of “serious cardiovascular events.”

Are Clinical Scales Useful for Adult ADHD?

Patients often come into my office to be “tested for ADHD,” and I explain to them that the diagnosis depends on a thorough clinical interview. Nonetheless, rating scales can be useful.

The Value of an ADHD Diagnosis

A Patient’s Perspective

Sparlon and ADHD: The Power of a 7-Year Old

Rarely has a 7-year old with a rash caused the stock price of a major corporation to gyrate so dramatically.

Daytrana: A Long and Winding Road to Approval

On April 6, 2006, the FDA announced the approval of Daytrana, a transdermal patch version of Ritalin (methylphenidate). While you wouldn’t know it by the gushy promotional copy on Daytrana’s website (www.daytrana.com), the Ritalin patch just barely squeaked through the FDA approval process.

Psychostimulants and ADHD

Recently three new psychostimulant formulations have been approved (Daytrana, the Ritalin patch, and Focalin XR), and one older medication received a new indication (Adderall XR is now indicated for adult ADHD).

Dopamine: Getting Reaquainted

Dopamine is the new serotonin: everyone is talking about it. Depending on what authority you read, dopamine is central to schizophrenia, ADHD, depression, sexuality, and cognition.

The Latest on ADHD

The last time we did an entire issue on ADHD was in September of 2006. In this brief article, we’ll bring you up to date on some recent developments.

Click here to view mobile site

Current Issue

ADHD

February, 2012
Vol: 10 Issue: 2
Read More
Previous Issues

Topics

ADHD
Antidepressants
Antipsychotics
Anxiety Disorder
Benzodiazepines
Bipolar Disorder
Brain Devices
Child Psychiatry
Computers in Psychiatric Practice
Dementia
Depressive Disorder
Diagnostic Testing
Eating Disorders
Genetics and Psychiatry
Health Care Policy
HIPAA
Hypnotics
Laboratory Testing in Psychiatry
Mood Stabilizers
Natural Medications
Neuroscience in Psychiatry
Novel Anticonvulsants
OCD
Personality Disorders
Pharmaceutical Industry
Practice Tools and Tips
Psychopharmacology Tips
Psychotherapy
PTSD
Research Updates
Seasonal Affective Disorder
Sexual Dysfunction
Smoking Cessation Agents
Substance Abuse
Understanding Psychiatric Research
Weight Loss Medications
Women's Issues in Psychiatry
Printer-friendly version
Medication Fact Sheets

Search

Follow Us

The Carlat Report Twitter Feed
Carlat Report RSS
The Carlat Report Blog
The Carlat Report Fan Page

The 2011 TCPR Atypical Antipsychotics Table is Now Available!

Updated November 2011: Click here to see TCPR's 2011 Atypical Antipsychotics Table.